covaxin: Covaxin well tolerated, phase 3 data shows 77.8% efficacy against symptomatic Covid: Lancet
India News: A week after the World Health Organisation (WHO) granted Emergency Use Listing (EUL) to Covaxin, a prestigious medical journal Lancet has stated tha...
Du måste logga in före du kommenterar